FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947951266> ?p ?o ?g. }

• W2947951266 abstract "e18065 Background: Utilization of NGS-based testing for patients in community oncology settings continues to grow. A comprehensive analysis of the molecular landscape of > 14,000 patients with commercial tissue-based and plasma-based NGS (tbNGS and pbNGS) testing from Sarah Cannon’s (SC) network of community oncologists between 2012 and 2018 was performed. These data aid clinical trial design/feasibility and identify rare and actionable mutations in the community oncology setting. Methods: Medical Oncologists in the SC network ordered NGS-based molecular profiling for their patients as standard of care. Data from multiple commercial vendors starting in 2012 were harmonized and analyzed. Results: On average, tbNGS (n = 8938) and pbNGS (n = 5419) tests revealed 14 and 4 mutations/sample, respectively. The top 10 mutated genes from both tbNGS and pbNGS - tests are in the table. The most predominant mutation-types detected were SNVs in both tbNGS and pbNGS tests, and gene amplifications were detected in ~40% of tbNGS and ~22% of pbNGS tests. MET amplifications (range: 2 - 40 copies (pbNGS) and 6 - 82 copies (tbNGS)) and ERBB2 amplifications (range: 2.1 - 90.2 copies (pbNGS) and 4 - 293 copies (tbNGS)) were detected in 1.6% (MET-tbNGS) and 4.6% (MET-pbNGS) and 4.2% (ERBB2-tbNGS) and 2.69% (ERBB2-pbNGS) of patients, respectively, and informed clinical trial enrollment. Of the fusions detected, 28 NTRK rearrangements were detected (NTRK1 – 16, NTRK2 – 5, NTRK3 – 7) by tissue-based testing and 3 (NTRK1) fusions were detected by plasma-based tests. Conclusions: These data describe the mutational landscape of NGS tests ordered within community oncology practices. SC’s data infrastructure links NGS-based testing data and clinical data to support real world evidence research, and highlights the need for healthcare IT systems to marry clinical and genomic data for clinical decision support and clinical research. [Table: see text]" @default.
• W2947951266 created "2019-06-07" @default.
• W2947951266 creator A5015191161 @default.
• W2947951266 creator A5018054038 @default.
• W2947951266 creator A5030148558 @default.
• W2947951266 creator A5044134049 @default.
• W2947951266 creator A5047536756 @default.
• W2947951266 creator A5055016088 @default.
• W2947951266 creator A5058306932 @default.
• W2947951266 creator A5058608470 @default.
• W2947951266 creator A5065490907 @default.
• W2947951266 creator A5065565118 @default.
• W2947951266 creator A5072308451 @default.
• W2947951266 creator A5073609375 @default.
• W2947951266 creator A5076581295 @default.
• W2947951266 creator A5076615101 @default.
• W2947951266 date "2019-05-20" @default.
• W2947951266 modified "2023-09-24" @default.
• W2947951266 title "Mutational analysis of >14,000 solid tumor NGS tests from community oncology practices: The Sarah Cannon molecular landscape." @default.
• W2947951266 doi "https://doi.org/10.1200/jco.2019.37.15_suppl.e18065" @default.
• W2947951266 hasPublicationYear "2019" @default.
• W2947951266 type Work @default.
• W2947951266 sameAs 2947951266 @default.
• W2947951266 citedByCount "0" @default.
• W2947951266 crossrefType "journal-article" @default.
• W2947951266 hasAuthorship W2947951266A5015191161 @default.
• W2947951266 hasAuthorship W2947951266A5018054038 @default.
• W2947951266 hasAuthorship W2947951266A5030148558 @default.
• W2947951266 hasAuthorship W2947951266A5044134049 @default.
• W2947951266 hasAuthorship W2947951266A5047536756 @default.
• W2947951266 hasAuthorship W2947951266A5055016088 @default.
• W2947951266 hasAuthorship W2947951266A5058306932 @default.
• W2947951266 hasAuthorship W2947951266A5058608470 @default.
• W2947951266 hasAuthorship W2947951266A5065490907 @default.
• W2947951266 hasAuthorship W2947951266A5065565118 @default.
• W2947951266 hasAuthorship W2947951266A5072308451 @default.
• W2947951266 hasAuthorship W2947951266A5073609375 @default.
• W2947951266 hasAuthorship W2947951266A5076581295 @default.
• W2947951266 hasAuthorship W2947951266A5076615101 @default.
• W2947951266 hasConcept C121608353 @default.
• W2947951266 hasConcept C126322002 @default.
• W2947951266 hasConcept C143998085 @default.
• W2947951266 hasConcept C2777362581 @default.
• W2947951266 hasConcept C29537977 @default.
• W2947951266 hasConcept C2993640289 @default.
• W2947951266 hasConcept C3020497934 @default.
• W2947951266 hasConcept C71924100 @default.
• W2947951266 hasConceptScore W2947951266C121608353 @default.
• W2947951266 hasConceptScore W2947951266C126322002 @default.
• W2947951266 hasConceptScore W2947951266C143998085 @default.
• W2947951266 hasConceptScore W2947951266C2777362581 @default.
• W2947951266 hasConceptScore W2947951266C29537977 @default.
• W2947951266 hasConceptScore W2947951266C2993640289 @default.
• W2947951266 hasConceptScore W2947951266C3020497934 @default.
• W2947951266 hasConceptScore W2947951266C71924100 @default.
• W2947951266 hasLocation W29479512661 @default.
• W2947951266 hasOpenAccess W2947951266 @default.
• W2947951266 hasPrimaryLocation W29479512661 @default.
• W2947951266 hasRelatedWork W2980949146 @default.
• W2947951266 isParatext "false" @default.
• W2947951266 isRetracted "false" @default.
• W2947951266 magId "2947951266" @default.
• W2947951266 workType "article" @default.